BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10389658)

  • 1. Application of positron emission tomography to determine cerebral glucose utilization in conscious infant monkeys.
    Moore AH; Cherry SR; Pollack DB; Hovda DA; Phelps ME
    J Neurosci Methods; 1999 May; 88(2):123-33. PubMed ID: 10389658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in cerebral glucose metabolism in conscious infant monkeys during the first year of life as measured by positron emission tomography.
    Moore AH; Hovda DA; Cherry SR; Villablanca JP; Pollack DB; Phelps ME
    Brain Res Dev Brain Res; 2000 Apr; 120(2):141-50. PubMed ID: 10775767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
    Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
    J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
    Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
    J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.
    Cross DJ; Minoshima S; Nishimura S; Noda A; Tsukada H; Kuhl DE
    J Nucl Med; 2000 Nov; 41(11):1879-87. PubMed ID: 11079499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental changes in brain metabolism in sedated rhesus macaques and vervet monkeys revealed by positron emission tomography.
    Jacobs B; Chugani HT; Allada V; Chen S; Phelps ME; Pollack DB; Raleigh MJ
    Cereb Cortex; 1995; 5(3):222-33. PubMed ID: 7613078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
    Kim IJ; Kim SJ; Kim YK
    Acta Radiol; 2009 Dec; 50(10):1169-74. PubMed ID: 19922315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study.
    O'Connell MT; Seal A; Nortje J; Al-Rawi PG; Coles JP; Fryer TD; Menon DK; Pickard JD; Hutchinson PJ
    Acta Neurochir Suppl; 2005; 95():165-8. PubMed ID: 16463843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of in vivo brain imaging method in conscious mice.
    Mizuma H; Shukuri M; Hayashi T; Watanabe Y; Onoe H
    J Nucl Med; 2010 Jul; 51(7):1068-75. PubMed ID: 20554730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study.
    Kinnala A; Suhonen-Polvi H; Aärimaa T; Kero P; Korvenranta H; Ruotsalainen U; Bergman J; Haaparanta M; Solin O; Nuutila P; Wegelius U
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
    Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
    J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
    Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harderian gland adenectomy: a method to eliminate confounding radio-opacity in the assessment of rat brain metabolism by 18F-fluoro-2-deoxy-D-glucose positron emission tomography.
    Brammer DW; Riley JM; Kreuser SC; Zasadny KR; Callahan MJ; Davis MD
    J Am Assoc Lab Anim Sci; 2007 Sep; 46(5):42-5. PubMed ID: 17877327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of microPET performance in analyzing the rat brain under different types of anesthesia: comparison between quantitative data obtained with microPET and ex vivo autoradiography.
    Matsumura A; Mizokawa S; Tanaka M; Wada Y; Nozaki S; Nakamura F; Shiomi S; Ochi H; Watanabe Y
    Neuroimage; 2003 Dec; 20(4):2040-50. PubMed ID: 14683708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure.
    Nishizawa S; Kuwabara H; Ueno M; Shimono T; Toyoda H; Konishi J
    Ann Nucl Med; 2001 Jun; 15(3):203-7. PubMed ID: 11545189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
    Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
    Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.